These findings suggest that FGF2/FGFR signaling pathway may play a crucial role in maintaining microglial resting status and the balance of pro- and anti-inflammatory cytokines, which provide new insights into the understanding of the antidepressant effect of FGF2 as well as the mechanism of neuroinflammation-associated depression. This evidence concerns the gene FGF2 and depressive disorder.